Amyloidosis and device therapy: an open debate

Egle Corrado, Salvatore Novo, Eluisa La Franca, Gianfranco Ciaramitaro, Giuseppe Coppola, Giuseppe Inga

Research output: Contribution to journalArticle


Cardiac involvement represents a critical prognostic factor inamyloidosis, as it represents a leading cause of morbidity and mortality,in primary light chain amyloidosis, in hereditary and alsoin wild-type transthyretin amyloidosis. A 54-year-old male wasadmitted to Emergency Room with complaints of dyspnea, palpitationsand diaphoresis.
Original languageEnglish
Pages (from-to)497-498
Number of pages2
Publication statusPublished - 2017

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Amyloidosis and device therapy: an open debate'. Together they form a unique fingerprint.

  • Cite this

    Corrado, E., Novo, S., La Franca, E., Ciaramitaro, G., Coppola, G., & Inga, G. (2017). Amyloidosis and device therapy: an open debate. INTERNATIONAL ANGIOLOGY, 497-498.